Tanya Gupta, M.D.
Investigator
Tanya Gupta, M.D., is a medical oncologist at the Palo Alto Medical Foundation whose clinical and research interests center on breast cancer. At Stanford, she served as a Clinical Assistant Professor, led breast medical oncology trials at the South Bay campus, and participated in an investigator-initiated study evaluating circulating tumor DNA in patients with early-stage triple-negative breast cancer following neoadjuvant chemotherapy. Her scholarly work has addressed triple-negative and hereditary breast cancer, PARP inhibitors, immunotherapy, treatment-related comorbidities, and novel biomarkers. She received an ASCO/Conquer Cancer Career Development Award supporting her investigation of circulating tumor DNA in patients with residual triple-negative breast cancer. Dr. Gupta completed her residency, chief residency, and hematology and oncology fellowship at Stanford. She earned her medical degree from the UC San Diego School of Medicine and has presented her research at national and international oncology conferences.
Clinical trials
- Clinical trial
Advanced Breast Cancer HR+ HER2- WO45654
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor and Letrozole in Patients With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Status: Open to Enrollment